Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves’ disease patients during methimazole treatment
IntroductionMethimazole (MMI) represents the conventional therapeutic agent for Graves’ disease (GD) hyperthyroidism, but MMI efficacy is limited since it marginally affects the underlying autoimmune process. In a previous study, we randomly assigned 42 newly diagnosed GD patients with insufficient...
Главные авторы: | , , , , , , , , , , |
---|---|
Формат: | Статья |
Язык: | English |
Опубликовано: |
Frontiers Media S.A.
2023-04-01
|
Серии: | Frontiers in Endocrinology |
Предметы: | |
Online-ссылка: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1145811/full |